HRT supply chain failures have left pharmacies across the UK and US unable to fill prescriptions for oestrogen patches and other hormone therapies. The shortages stem from manufacturing problems, demand surges, and regulatory delays. Trans people on feminising HRT are among those most affected, and knowing your options matters.
What is actually happening to the HRT supply?
If you have stood at a pharmacy counter and been told your prescription cannot be filled, or been handed a partial supply and told to come back next week, you are not imagining things. HRT shortages have been a recurring problem in the UK and the US for several years now, and they have been getting worse rather than better. Oestrogen patches in particular keep appearing on medicines shortage lists, alongside progesterone capsules, testosterone gel, and various other formulations that trans and menopausal people depend on.
The causes are structural rather than accidental. A relatively small number of pharmaceutical manufacturers produce the hormones used in HRT, which means that when one plant has a problem, whether that is a contamination issue, a regulatory hold, a raw materials disruption, or simply a line going down for maintenance, the shortfall ripples immediately into pharmacy stock. There is no slack in the system, and there has not been for a long time.
At the same time, demand for HRT has grown substantially. Greater public awareness of menopause care, expanded access through specialist services, and the growing number of trans people accessing gender-affirming hormone therapy have all contributed. The manufacturing base has not kept pace. When demand rises and supply is fragile, shortages follow.
Why trans people are hit particularly hard
For someone going through menopause, a temporary patch shortage is disruptive and uncomfortable. For a trans woman or non-binary person on feminising HRT, the disruption can feel like something more than inconvenience. Oestrogen is not a lifestyle supplement: it is the medication that makes it possible to live in a body that feels right. An interruption to supply can cause anxiety, distress, and in some cases real physical effects if hormones drop sharply.
There is also a practical layer that is harder for trans people to navigate. Switching formulations, requesting an urgent alternative, or pushing back on a pharmacy that says nothing is available all require a degree of confidence in dealing with healthcare providers that not everyone has. Trans people already face higher rates of poor treatment and dismissal in medical settings. The idea of going back to explain the situation again, to someone new, in an already pressured system, puts up a real barrier.
And unlike someone who has been managing menopause for years and knows their options, someone newer to HRT may not know that alternatives exist, or that switching formulations mid-cycle is something a prescriber can help with safely.
Which formulations are affected and which are not
Oestrogen patches have been the most frequently shortage-affected formulation in both the UK and the US. Specific brands have appeared on the UK's Category M shortage list and the US FDA drug shortage database repeatedly. The shortage does not always affect every strength or every manufacturer at the same time, which is why it is worth asking a pharmacist to check whether a different brand of patch in the same dose is available, even when your usual one is not.
Oestrogen gel has generally been more consistently available, though it too has seen intermittent supply problems. The same is true of oestrogen sprays. Oral oestradiol tablets have tended to be more reliably stocked, partly because they involve a simpler manufacturing process. Progesterone capsules have had their own separate shortage issues, particularly in the UK.
Testosterone gel, used in masculinising HRT, has also faced supply problems. These tend to affect trans men and non-binary people on testosterone in the same way: a medication that is central to daily life becomes suddenly hard to obtain, with little warning and no obvious timeline for resolution.
What you can do if your prescription cannot be filled
The first thing is to ask the pharmacist specifically whether a different brand of the same formulation is in stock, or whether a neighbouring branch has it. Pharmacies in the same chain do not always share stock information automatically, and a short trip or a call to another branch sometimes resolves the problem quickly.
If no patch is available anywhere local, the next step is to contact whoever prescribes your HRT and ask whether you can be switched to a different formulation temporarily. Gel, spray, or oral oestradiol can all deliver oestrogen effectively, and a prescriber who understands HRT will be able to advise on an equivalent dose. This is not a dangerous switch when it is done with guidance: the aim is simply to keep your oestrogen levels stable while the supply situation resolves.
Specialist pharmacies, sometimes called compounding pharmacies, can sometimes prepare formulations that are not commercially available or that are in short supply. This tends to cost more and is not always an option, but it is worth knowing about if you are genuinely stuck.
Keep a record of what you have tried. If you need to escalate, whether to a GP, a prescriber, a gender service, or in the case of the UK, to NHS England's medicines supply team, having a clear account of the shortage and your attempts to resolve it strengthens your position.
What the shortage tells us about how HRT is valued
I have been hearing about these shortages for years, and what strikes me most is not the individual supply failures, which are real and serious, but what they reveal about how hormone therapy is valued by the systems that are supposed to provide it. Medications that people depend on for daily functioning, for their sense of self, for their physical and mental health, should not be treated as a niche product with a fragile supply chain and no contingency planning.
The political climate has not helped. In the US, the regulatory uncertainty around gender-affirming care under recent administrations has made pharmaceutical manufacturers more cautious about investing in capacity for trans healthcare products specifically. In the UK, the conversation about trans healthcare has been so dominated by gatekeeping debates that the basic infrastructure question, can people actually get their medication when they need it, has received almost no attention.
Delay is not neutral here, just as it is not neutral in any other area of medicine. When someone cannot get their oestrogen for a week, or two weeks, or longer, that is not a minor administrative inconvenience. It is a failure of care.
Longer-term steps worth knowing about
Asking your prescriber to give you a slightly longer supply when things are available is a reasonable request, particularly if you live somewhere with limited pharmacy access or have had repeated supply problems. A 90-day supply instead of a 30-day one gives you buffer time if shortages recur.
It is also worth knowing what alternative formulations exist before you are in an urgent situation. Having that conversation with your prescriber when things are stable, so that you know what your options are and what dose equivalent would apply, means you can act quickly if you need to.
Some people find it helpful to build a small reserve when supply is good, within the terms of their prescription. This is a personal decision, but for someone who has been caught out before, it is a practical one.
If you are accessing HRT through a private provider and they can prescribe across formulations, that flexibility can be genuinely useful during a shortage. If you are not sure whether your prescriber can help you switch, ask directly: in most cases they can, and it is a simpler conversation than people often expect.
If you are finding this difficult to navigate
Dealing with a shortage of medication you depend on is stressful, and it is even more stressful when that medication is tied to your identity and your sense of yourself. If you are struggling to sort out your supply and your own doctor or pharmacy is not helping, and you need someone with real expertise in gender-affirming care, GenderGP at gendergp.com can help with access to prescriptions and ongoing support.
For thinking it through, understanding your options, or just making sense of what is happening, Sammy and I are here.
Comments